Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Emerging
Primary summary from verified readiness
- Confidence
- 66% · stale
- Computed at
- 2026-07-27T18:59:01.472053+00:00
- Claimed
- 45
- Reported
- 38
- Verified
- 28
- Gap
- +17
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-07-27
Track; not yet
- Why
- The Slayman case proved surgical/immunological feasibility of a 69-edit CRISPR pig kidney in a living human and opened the modern xenotransplant era, but rejection remains unresolved (Looney's kidney failed at 4mo9d) and the patient count is still single digits under expanded-access/early trial protocols -- genuinely promising, not yet a repeatable clinical modality.
- Next
- Re-check when eGenesis's FDA-cleared (2025-09-08) Phase 1/2/3 EGEN-2784 trial reports interim safety/efficacy data on additional enrolled patients, or when a recipient surpasses 12 months rejection-free -- whichever comes first.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 0
- Tier 2
- 5
- Tier 3
- 1
- Supports
- 3
- Contradicts
- 2
- Context
- 1
- Latest observed
- 2025-09-08
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-27 Reading moved from emerging to emerging.